info icon

Contusion of toe(s) without damage to nail

ST19_CONTU_TOES_WO_DAMAGE_NAIL

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 S90.1
  • Cause of death: ICD-10 S90.1

2 out of 7 registries used, show all original rules.

939

4. Check minimum number of events

None

939

5. Include endpoints

None

939

6. Filter based on genotype QC (FinnGen only)

939

Control definitions (FinnGen only)

Control exclude
ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S90
Name in latin
Contusio digiti/digitorum pedis sine laesione unguis/unguium

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 939 632 307
Unadjusted period prevalence (%) 0.19 0.22 0.14
Median age at first event (years) 40.90 39.03 44.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
818
Matched controls
8181
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S90.1
ICD-10 Finland
Contusion of toe(s) without damage to nail
+∞
323.0
818
51
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
13.9
127.1
233
227
W22
ICD-10 Finland
Striking against or struck by other object(s)
12.3
109.8
213
228
X59
ICD-10 Finland
Exposure to unspecified factor
4.3
56.5
247
742
X58
ICD-10 Finland
Exposure to other specified factors
4.6
51.4
204
551
S93.4
ICD-10 Finland
Sprain and strain of ankle
5.9
48.7
147
291
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.2
41.5
267
1063
M79.6
ICD-10 Finland
Pain in limb
2.7
36.4
335
1654
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
10.4
32.2
64
66
M54.5
ICD-10 Finland
Low back pain
2.3
24.1
307
1708
S92.5
ICD-10 Finland
Fracture of other toe
9.9
22.3
45
48
L17
ICPC
Foot/toe symptom/complaint
2.4
21.9
237
1209
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
20.9
337
2052
M25.5
ICD-10 Finland
Pain in joint
2.1
18.3
258
1463
N02AX02
ATC
tramadol; systemic, rectal
2.0
18.2
307
1877
J01DB01
ATC
cefalexin; oral
2.2
17.8
683
5687
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
17.3
151
681
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
16.2
305
1922
N02BE01
ATC
paracetamol; systemic, rectal
2.1
16.1
669
5583
S92.4
ICD-10 Finland
Fracture of great toe
15.1
15.4
25
17
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.9
15.4
100
377
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
15.4
216
1208
M01AB05
ATC
diclofenac; systemic, rectal
1.8
15.3
504
3824
W20
ICD-10 Finland
Struck by thrown, projected or falling object(s)
13.4
15.3
26
20
N03AX16
ATC
pregabalin; oral
2.2
15.0
174
896
J01FF01
ATC
clindamycin; systemic
2.0
15.0
216
1221
W19
ICD-10 Finland
Unspecified fall
3.1
15.0
85
294
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.0
14.7
59
155
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
17.4
14.4
22
13
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
13.9
150
744
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
13.7
338
2300
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.7
13.6
100
405
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
13.6
90
344
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
6.4
13.2
34
55
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
13.1
138
678
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
13.0
216
1281
M01AH05
ATC
etoricoxib; oral
1.7
12.9
435
3243
S80.0
ICD-10 Finland
Contusion of knee
3.1
12.7
71
241
L12
ICPC
Hand/finger symptom/complaint
2.2
12.5
135
669
M03BX02
ATC
tizanidine; oral
1.7
12.4
467
3584
S92.3
ICD-10 Finland
Fracture of metatarsal bone
8.9
12.1
25
29
R4110
NOMESCO Finland
Physiotherapy
1.9
12.1
202
1194
R03DC03
ATC
montelukast; oral
2.1
12.0
146
763
R03AC02
ATC
salbutamol; inhalant
1.7
12.0
427
3208
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
11.5
423
3191
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
11.4
278
1858
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
11.4
154
837
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
3.9
11.2
45
119
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
11.2
80
319
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
25.4
11.2
15
6
S91.3
ICD-10 Finland
Open wound of other parts of foot
7.5
11.0
25
34
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
11.0
107
506
R4120
NOMESCO Finland
Occupational therapy
3.1
10.9
59
199
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
7.3
10.8
25
35
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.7
10.8
74
288
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
10.4
426
3270
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
10.3
193
1179
H02AB06
ATC
prednisolone; systemic
1.7
10.3
328
2353
S20.2
ICD-10 Finland
Contusion of thorax
3.7
10.2
44
125
S18
ICPC
Laceration/cut
1.7
10.1
293
2045
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
10.0
251
1680
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.0
10.0
31
64
S06.0
ICD-10 Finland
Concussion
2.3
9.9
92
422
L03
ICPC
Low back symptom/complaint
1.8
9.8
189
1164
A02BC02
ATC
pantoprazole; systemic
1.6
9.8
438
3421
N03AX12
ATC
gabapentin; oral
2.1
9.8
116
597
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.6
9.8
72
294
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
9.7
135
741
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.6
9.7
43
125
W10
ICD-10 Finland
Fall on and from stairs and steps
3.6
9.7
43
125
A29
ICPC
General symptom/complaint other
2.3
9.7
89
409
N30.0
ICD-10 Finland
Acute cystitis
2.1
9.7
119
622
ZXA00
NOMESCO Finland
Right side
1.9
9.6
170
1014
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.6
199
1254
R74
ICPC
Upper respiratory infection acute
1.7
9.6
279
1945
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.5
191
1191
Z3226
NOMESCO Finland
Physiotherapist
1.9
9.5
142
799
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
9.5
166
991
H02AB04
ATC
methylprednisolone; systemic
2.2
9.5
103
510
J01FA06
ATC
roxithromycin; oral
1.6
9.3
285
2013
R42
ICD-10 Finland
Dizziness and giddiness
1.9
9.3
140
790
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
9.2
137
771
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
9.2
243
1645
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
9.2
71
296
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
5.0
9.2
28
57
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
9.2
279
1962
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
9.2
87
404
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
9.0
245
1669
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
4.2
8.9
33
82
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
8.9
108
562
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
8.8
66
271
R51.80
ICD-10 Finland
Headache
1.9
8.8
135
767
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
8.8
96
475
W23
ICD-10 Finland
Caught, crushed, jammed or pinched in or between objects
7.3
8.8
20
28
Z3231
NOMESCO Finland
Registered nurse
1.7
8.7
212
1396
J01FA10
ATC
azithromycin; systemic
1.6
8.7
500
4099
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
8.7
389
3004
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
8.7
132
748
M79.1
ICD-10 Finland
Myalgia
2.0
8.6
110
584
J01AA02
ATC
doxycycline; systemic
1.6
8.6
540
4516
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
8.6
231
1566
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
8.5
101
519
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
8.5
107
565
S90.0
ICD-10 Finland
Contusion of ankle
6.1
8.5
22
37
R05
ICPC
Cough
1.7
8.4
178
1124
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.3
8.3
40
125
R03BA05
ATC
fluticasone; inhalant
1.8
8.2
144
855
X57
ICD-10 Finland
Unspecified privation
5.2
8.2
24
47
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
5.5
8.2
23
43
ZXD05
NOMESCO Finland
Urgent procedure
1.6
8.1
234
1613
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.4
8.1
37
111
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.2
8.1
41
133
J01CA04
ATC
amoxicillin; systemic
1.7
8.1
679
6062
S22.3
ICD-10 Finland
Fracture of rib
3.0
8.1
46
160
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.1
8.1
96
495
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.8
8.1
49
180
R60.0
ICD-10 Finland
Localized oedema
2.4
7.9
66
287
R52.9
ICD-10 Finland
Pain, unspecified
2.4
7.9
66
287
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
7.9
79
377
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.9
131
764
WX110
NOMESCO Finland
Local anesthesy
1.5
7.8
560
4774
R01AD09
ATC
mometasone; nasal
1.5
7.8
357
2748
L86
ICPC
Back syndrome with radiating pain
3.0
7.7
44
153
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.2
7.7
38
121
N05BA04
ATC
oxazepam; oral
1.7
7.7
178
1153
ZXE00
NOMESCO Finland
One hour or less
1.5
7.5
296
2193
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
7.5
148
914
R01AD08
ATC
fluticasone; nasal
1.6
7.5
217
1493
L05
ICPC
Flank/axilla symptom/complaint
2.8
7.5
45
165
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
7.4
139
843
S63.5
ICD-10 Finland
Sprain and strain of wrist
3.1
7.4
38
125
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.4
7.3
60
260
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.3
154
969
P99
ICPC
Psychological disorders other
3.7
7.3
30
83
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
9.5
7.3
14
15
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.4
7.3
62
273
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
7.3
712
6492
R21
ICPC
Throat symptom/complaint
1.6
7.2
218
1514
SPAT1283
SPAT
Restricted health certificate
1.6
7.2
199
1352
S50.0
ICD-10 Finland
Contusion of elbow
3.5
7.2
32
95
D06
ICPC
Abdominal pain localized other
2.2
7.1
69
324
R03AC13
ATC
formoterol; inhalant
3.0
7.1
38
129
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.0
7.1
89
469
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.0
7.1
39
135
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.1
202
1383
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.9
7.1
41
146
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.1
7.1
37
124
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
7.1
116
675
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
7.0
73
354
R96
ICPC
Asthma
2.3
7.0
63
287
J01FA09
ATC
clarithromycin; systemic
1.6
6.9
245
1765
Y94.8
ICD-10 Finland
Other leisure activity accident
3.8
6.9
27
72
A02BC05
ATC
esomeprazole; systemic
1.5
6.9
261
1913
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
6.9
62
281
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
6.9
45
174
F51.0
ICD-10 Finland
Nonorganic insomnia
1.9
6.9
109
626
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
5.4
6.8
19
36
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.8
80
410
Y94.0
ICD-10 Finland
Accident at home
5.7
6.8
18
32
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
6.8
45
176
NHE20
NOMESCO Finland
Plastic repair of capsule or ligament of ankle joint with transplant
16.9
6.8
10
6
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.6
6.8
47
187
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
6.7
33
106
R13
ICD-10 Finland
Dysphagia
2.7
6.7
44
170
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.7
282
2111
NHQ40
NOMESCO Finland
Amputation of toe
7.9
6.6
14
18
D11
ICPC
Diarrhoea
1.9
6.6
100
564
L08
ICPC
Shoulder symptom/complaint
1.8
6.6
117
696
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
6.6
138
868
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
6.6
31
97
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.2
6.5
32
103
W55
ICD-10 Finland
Bitten or struck by other mammals
3.0
6.5
35
121
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
6.5
416
3397
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
6.4
95
534
ZXA05
NOMESCO Finland
Left side
1.7
6.4
145
933
WX290
NOMESCO Finland
Other blockade of nerve
1.5
6.4
386
3114
L15
ICPC
Knee symptom/complaint
1.7
6.3
148
959
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
6.3
321
2497
Y96.8
ICD-10 Finland
Other type of accident
9.3
6.3
12
13
A01
ICPC
Pain general/multiple sites
2.2
6.3
59
276
J01DA01
ATC
[U] cefalexin; systemic
1.4
6.3
455
3795
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.2
148
963
B01AB05
ATC
enoxaparin; parenteral
1.6
6.2
172
1163
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.5
6.2
45
186
M24.2
ICD-10 Finland
Disorder of ligament
5.4
6.2
17
32
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.1
461
3868
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
6.1
57
265
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.1
119
730
S93.5
ICD-10 Finland
Sprain and strain of toe(s)
8.7
6.1
12
14
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.1
6.1
64
314
L01
ICPC
Neck symptom/complaint
1.8
6.0
99
576
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
6.0
46
194

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002582) Erythrocytes [#/volume] in Urine
327
1958
2.03
21.92
3.9
2.8
e6/l
84.3
77.3
0.05
270
1466
(3030467) Casts [#/volume] in Urine by Automated count
298
1775
1.99
19.93
3.8
2.8
e6/l
0.4
0.4
0.03
234
1306
(3033658) Prothrombin time (PT) actual/Normal
287
1705
1.98
19.22
4.8
3.7
%
92.2
94.1
0.63
279
1660
(36304419) Bacteria [Presence] in Urine
294
1769
1.96
18.93
3.6
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
130
570
2.49
18.52
16.6
15.2
inr
1.1
1.2
0.88
21
93
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
191
999
2.14
17.96
3.6
2.6
e6/l
3.0
3.1
0.03
113
527
(3018095) Leukocytes [#/volume] in Urine
367
2432
1.84
17.21
4.6
3.3
e6/l
99.4
67.7
0.51
285
1600
(3026782) Osmolality of Urine
223
1255
2.02
17.15
2.9
2.5
mosm/kgh2o
563.6
555.8
0.19
193
1071
(3000850) Epithelial cells [#/volume] in Urine
232
1332
1.99
16.83
2.6
2.3
e6/l
6.4
7.6
0.51
210
1167
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
177
921
2.14
16.78
1.8
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
525
3906
1.78
16.41
5.6
4.3
mmol/l
6.7
6.5
1.58
502
3547
(3042936) Bacteria identified in Isolate by Culture
166
865
2.12
15.60
2.3
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
192
1064
2.01
15.25
4.7
3.1
ng/l
220.3
502.1
0.75
139
688
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
458
3340
1.72
14.79
5.5
5.8
umol/l
10.2
11.1
1.74
427
3142
(3026008) Bacteria identified in Urine by Culture
301
1951
1.80
14.69
3.2
2.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
242
1483
1.85
14.11
4.3
3.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
151
791
2.08
13.91
2.2
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
387
2730
1.71
13.83
6.8
5.9
mmol/l
1.2
1.2
0.60
356
2485
(40758558) Short blood count panel - Blood
285
1846
1.78
13.79
7.3
6.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
185
1051
1.95
13.55
3.4
2.5
e6/l
1.0
0.9
0.12
106
575
(3013707) Erythrocyte sedimentation rate by Westergren method
659
5417
1.73
12.80
4.1
3.7
mm/h
9.8
9.9
0.06
621
5055
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
418
3059
1.66
12.69
7.6
6.4
mmol/l
1.2
1.2
0.00
370
2606
(3000991) Gas panel - Venous blood
101
472
2.28
12.34
8.9
8.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
130
672
2.08
12.34
7.6
6.8
mmol/l
104.5
104.3
0.15
125
656
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
253
1636
1.75
12.07
2.0
1.9
mg/l
0.8
1.0
0.66
190
1198
(3031040) Bacteria [#/volume] in Urine by Automated count
601
4881
1.64
11.61
5.5
3.7
e6/l
3513.6
344.0
—
7
57
(3019550) Sodium [Moles/volume] in Serum or Plasma
836
7460
2.10
11.59
17.1
11.4
mmol/l
139.6
139.6
0.07
818
7250
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
299
2046
1.68
11.50
3.1
2.3
u/l
55.0
56.1
0.20
276
1885
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
121
626
2.07
11.44
1.7
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
838
7493
2.10
11.42
17.4
11.5
mmol/l
3.9
3.9
0.26
820
7270
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
788
6917
1.87
11.11
14.3
9.3
ml/min/173m2
91.4
90.8
0.30
669
5572
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
734
6326
1.73
10.82
3.9
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
266
1795
1.67
10.66
5.0
3.7
ph
7.4
7.4
0.70
39
334
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
119
632
2.01
10.45
1.7
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
489
3836
1.57
10.42
3.0
2.8
ug/l
84.3
87.1
0.18
463
3594
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
636
5309
1.61
10.33
7.6
6.7
u/l
76.6
76.6
0.00
605
4974
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
799
7091
1.85
10.23
4.7
4.5
mu/l
1.8
2.0
0.34
749
6644
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
853
7739
2.12
10.20
16.7
10.7
mg/l
20.5
20.9
0.16
712
5900
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
257
1758
1.64
9.62
2.7
2.1
u/l
142.9
239.2
0.99
245
1660
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
71
318
2.33
9.57
9.8
5.3
mmol/l
24.4
23.8
0.98
65
295
(42870588) Differential panel, method unspecified - Blood
334
2442
1.57
9.43
6.2
5.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
37
120
3.17
9.30
5.2
4.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
101
527
2.03
9.30
5.8
4.8
mmol/l
1.5
1.6
0.11
85
422
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
113
627
1.91
8.71
3.0
2.2
u/l
35.4
35.0
0.02
96
530
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
330
2452
1.53
8.46
2.0
1.8
pmol/l
94.4
96.7
0.43
193
1311
(3013650) Neutrophils [#/volume] in Blood by Automated count
527
4322
1.50
8.38
8.8
8.6
e9/l
4.2
3.9
2.95
477
3802
(3024561) Albumin [Mass/volume] in Serum or Plasma
349
2644
1.51
8.09
5.0
4.5
g/l
35.8
36.7
2.26
327
2464
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
65
304
2.22
7.94
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
692
6043
1.55
7.90
4.0
3.9
pmol/l
14.3
14.5
1.15
633
5580
(3052851) Hemolysis interference index of Serum or Plasma
43
167
2.65
7.86
2.8
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
606
5149
1.50
7.85
4.9
3.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
234
1636
1.57
7.78
3.6
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
135
821
1.75
7.72
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
197
1328
1.61
7.63
1.4
1.3
iu/ml
42.5
26.8
0.54
65
406
(3022096) Basophils/100 leukocytes in Blood
431
3448
1.46
7.43
7.1
5.9
%
0.6
0.7
1.09
402
3249
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
355
2.08
7.34
1.6
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
100
565
1.86
7.29
7.4
8.8
mmol/l
0.9
1.1
0.20
81
444
(3006504) Eosinophils/100 leukocytes in Blood
442
3568
1.45
7.19
6.9
5.8
%
2.8
2.8
0.04
411
3354
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
256
1861
1.52
7.05
2.4
2.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
291
2178
1.49
6.94
3.4
2.9
ng/l
17.0
33.6
3.84
159
1229
(40761511) CBC panel - Blood by Automated count
875
8189
2.01
6.87
13.8
10.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
322
2464
1.47
6.85
3.3
3.2
u/l
32.3
30.8
0.30
308
2344
(3019069) Monocytes/100 leukocytes in Blood
442
3592
1.44
6.81
7.1
6.1
%
8.2
8.3
0.27
412
3402
(3044640) Blood type and Crossmatch panel - Blood
296
2230
1.48
6.81
2.6
2.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
920
8797
3.26
6.79
22.9
15.9
pg
30.0
30.1
0.44
906
8688
(3024731) MCV [Entitic volume]
920
8798
3.26
6.77
22.9
15.9
fl
90.1
90.0
0.14
906
8690
(3026361) Erythrocytes [#/volume] in Blood
920
8799
3.25
6.75
22.9
15.9
e12/l
4.5
4.5
0.14
901
8570
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
100
579
1.81
6.74
2.4
2.5
g/l
0.2
0.2
0.02
85
544
(3010813) Leukocytes [#/volume] in Blood
920
8801
3.24
6.71
23.0
16.0
e9/l
6.8
6.7
1.19
902
8570
(3007461) Platelets [#/volume] in Blood
919
8790
3.14
6.63
23.0
16.0
e9/l
257.9
257.8
0.03
900
8578
(3000963) Hemoglobin [Mass/volume] in Blood
920
8807
3.21
6.58
23.1
16.0
g/l
135.7
136.1
0.43
907
8693
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
123
2.74
6.56
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
123
2.74
6.56
1.5
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
267
1983
1.48
6.55
3.2
3.2
mmol/l
7.4
8.2
2.06
238
1705
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
241
1754
1.50
6.53
2.5
2.0
mg/l
2.6
2.8
1.25
209
1516
(3032080) INR in Blood by Coagulation assay
301
2295
1.46
6.44
7.3
6.5
inr
1.2
1.1
0.34
107
749
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
374
2973
1.43
6.38
2.7
2.3
nmol/l
73.0
73.8
0.23
356
2746
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
276
2073
1.47
6.37
1.4
1.3
u/ml
1.5
1.7
0.07
61
573
(3003327) Ova and parasites identified in Stool by Light microscopy
59
291
2.10
6.35
1.4
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
460
3798
1.41
6.32
6.7
5.9
e9/l
0.0
0.0
0.15
414
3346
(3002030) Lymphocytes/100 leukocytes in Blood
452
3721
1.41
6.31
7.1
5.9
%
27.9
29.5
2.81
422
3519
(3013115) Eosinophils [#/volume] in Blood
473
3929
1.41
6.25
6.9
6.2
e9/l
0.2
0.2
0.48
437
3516
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
865
8100
1.86
6.25
10.8
8.7
u/l
25.9
26.2
0.18
842
7850
(3018010) Neutrophils/100 leukocytes in Blood
447
3677
1.41
6.25
6.9
5.7
%
57.8
56.1
2.53
417
3485
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
233
1702
1.49
6.16
2.4
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
545
4651
1.41
6.10
3.5
3.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
457
3789
1.40
6.03
6.7
5.9
e9/l
0.6
0.5
1.25
413
3337
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
282
2153
1.44
5.91
1.9
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
225
1646
1.48
5.88
2.5
2.4
umol/l
3792.5
4482.1
0.10
195
1459
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
236
2.14
5.63
1.9
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
180
1271
1.51
5.56
1.4
1.3
u/ml
24.8
12.1
0.65
66
528
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
378
1.89
5.56
2.6
2.7
ng/l
141.2
137.1
0.03
58
337
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
228
1690
1.46
5.54
2.3
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
467
3922
1.38
5.53
6.8
5.9
e9/l
1.9
2.0
0.60
434
3525
(3007164) IgA [Mass/volume] in Serum or Plasma
241
1808
1.45
5.49
1.5
1.4
g/l
2.2
2.2
0.25
149
1137
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
610
5358
1.40
5.46
3.6
2.9
u/l
40.2
39.8
0.06
583
5095
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
114
2.59
5.25
1.1
1.6
g/l
0.4
0.7
0.83
20
88
(3021601) Nitrite [Presence] in Urine by Test strip
445
3729
1.37
5.24
5.3
4.3
estimate
0.0
0.0
0.50
86
753
(3035350) Ketones [Presence] in Urine by Test strip
443
3711
1.37
5.22
3.8
3.1
estimate
0.0
0.0
0.00
79
734
(3021589) Normoblasts [#/volume] in Blood
408
3378
1.37
5.16
9.8
8.4
e9/l
0.0
0.0
0.72
347
2767
(3009542) Hematocrit [Volume Fraction] of Blood
810
7527
1.55
5.12
17.8
11.7
%
40.2
40.3
0.20
659
6052
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
417
3471
1.36
5.07
4.3
3.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
45
3.60
5.06
4.1
5.9
%
11.7
10.9
0.26
16
45
(3003458) Phosphate [Moles/volume] in Serum or Plasma
122
807
1.59
5.03
7.3
5.8
mmol/l
1.1
1.1
0.40
114
758
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
376
1.84
5.03
2.3
2.1
ug/l
7.2
6.7
0.07
58
339
(3021960) Folate [Moles/volume] in Serum or Plasma
190
1384
1.47
5.01
1.6
1.5
nmol/l
19.2
20.5
0.62
175
1202
(3014051) Protein [Presence] in Urine by Test strip
36
162
2.27
4.90
1.9
1.7
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
21
72
2.96
4.89
1.2
1.2
g/l
5.5
6.3
0.45
12
51
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
760
6991
1.46
4.84
3.9
3.6
mmol/l
5.8
5.7
0.91
703
6470
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
413
1.78
4.75
1.6
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
445
3767
1.34
4.75
3.9
3.1
estimate
0.0
0.0
0.52
82
727
(3045414) Leukocytes [Presence] in Urine
57
312
1.88
4.64
1.7
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
74
447
1.71
4.36
1.8
1.8
g/l
1.4
1.3
0.19
65
416
(3000330) Specific gravity of Urine by Test strip
54
297
1.87
4.34
3.1
3.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
72
2.82
4.30
1.1
1.2
g/l
0.4
0.3
0.49
12
49
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
72
2.82
4.30
1.1
1.2
g/l
2.7
2.7
0.05
12
50
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
121
828
1.53
4.30
2.9
2.3
%
21.5
23.4
1.01
110
721
(3004789) Transferrin [Mass/volume] in Serum or Plasma
131
912
1.51
4.30
2.7
2.2
g/l
2.5
2.4
0.15
120
842
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
220
2.00
4.27
2.0
1.7
—
—
—
0
0
(3036489) Thrombin time
54
299
1.86
4.26
2.9
2.6
s
21.4
21.4
0.01
46
266
(3012095) Magnesium [Moles/volume] in Serum or Plasma
139
983
1.49
4.23
3.6
3.7
mmol/l
0.8
0.8
0.49
134
926
(4062490)
20
73
2.78
4.20
1.2
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
67
400
1.73
4.13
5.3
7.9
mmol/l
24.6
24.8
0.25
67
400
(3019150) Specific gravity of Urine by Refractometry
212
1629
1.39
4.10
3.7
3.3
kg/l
1.0
1.0
0.02
30
218
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
94
614
1.59
4.10
2.9
2.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
139
991
1.47
4.06
2.8
2.2
umol/l
13.3
14.0
0.61
129
916
(40768797) Stomach Pathology biopsy report
124
867
1.50
3.99
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
171
1272
1.42
3.98
1.5
1.6
pmol/l
32414265.9
36306162.0
0.04
145
1099
(3000034) Microalbumin [Mass/volume] in Urine
15
48
3.16
3.94
2.5
2.7
mg/l
72.7
15.7
—
8
32
(3003338) MCHC [Mass/volume]
753
6992
1.39
3.88
20.1
13.7
g/l
332.5
333.3
1.47
746
6945
(3002385) Erythrocyte distribution width [Ratio]
729
6736
1.37
3.86
20.4
13.4
%
13.5
13.4
0.52
721
6610
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
17
60
2.87
3.80
1.4
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
86
561
1.59
3.79
2.3
2.6
g/l
10.5
10.5
0.04
73
514
(3020682) Albumin/Creatinine [Ratio] in Urine
213
1659
1.37
3.77
4.2
4.1
mg/mmol
14.7
10.0
0.59
148
1086
(3048689) Calprotectin [Mass/mass] in Stool
154
1138
1.42
3.72
2.2
2.4
ug/g
131.7
108.1
0.30
115
907
(3030981) Hyaline casts [#/volume] in Urine by Automated count
53
309
1.76
3.57
3.2
2.4
e6/l
0.1
0.1
0.67
53
299
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
105
2.32
3.54
1.8
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
202
1576
1.36
3.52
3.4
3.4
mg/l
1045.9
270.5
0.77
138
1060
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
140
2.11
3.40
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
77
503
1.58
3.39
2.4
2.5
e9/l
3.8
4.1
0.63
61
422
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
35
182
1.96
3.37
1.1
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
204
1.90
3.34
1.4
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
32
3.47
3.34
2.4
5.0
umol/l
290.5
167.8
—
6
18
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
72
465
1.59
3.33
2.1
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
71
458
1.60
3.30
2.3
2.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
170
1.98
3.27
1.2
2.5
g/l
2.6
3.0
2.45
22
143
(3019309) Folate [Moles/volume] in Red Blood Cells
134
989
1.41
3.26
1.7
1.6
nmol/l
1119.7
1164.9
0.26
102
761
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
139
1035
1.40
3.21
2.4
2.5
mmol/l
2.4
2.4
0.76
118
904
(44816559) Phosphatidylethanol [Mass/volume] in Blood
36
193
1.90
3.19
1.9
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
173
1339
1.36
3.16
2.7
2.9
ng/l
1490.1
837.7
0.78
149
1109
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
341
2899
1.28
3.16
3.9
3.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
51
306
1.70
3.14
4.7
7.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
334
2834
1.28
3.14
2.1
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
180
1.92
3.13
1.3
1.4
ug/g
335.1
323.7
0.09
16
103
(3015377) Calcium [Moles/volume] in Serum or Plasma
258
2120
1.30
3.11
2.5
3.0
mmol/l
2.3
2.4
0.42
228
1892
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
106
756
1.45
3.11
2.7
3.0
umol/l
5.0
7.5
2.45
95
639
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
768
7229
1.34
3.04
4.0
3.7
mmol/l
4.7
4.7
1.05
730
6830
(3037522) Nuclear Ab [Titer] in Serum
145
1099
1.38
3.02
1.4
1.3
titre
691.4
522.2
0.30
28
221
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
90
626
1.48
3.00
2.3
2.3
u/l
2892.8
4843.0
0.57
35
252
(3029937) Albumin [Presence] in Urine by Test strip
241
1974
1.30
2.96
4.1
3.3
estimate
0.0
0.0
1.08
82
739
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
150
1147
1.37
2.96
2.8
1.7
%
1.5
1.4
0.34
132
1036
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
28
142
2.00
2.92
1.2
2.7
g/l
40.5
39.1
0.64
21
133
(36660697) Celiac disease serology panel - Serum
100
714
1.45
2.92
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
178
1.89
2.90
1.2
2.4
g/l
6.9
7.2
0.67
22
150
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
178
1.89
2.90
1.2
2.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
33
178
1.89
2.90
4.2
4.2
mmol/l
1.1
1.4
0.95
33
173
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
178
1.89
2.90
1.2
2.4
g/l
3.4
3.7
0.99
22
140
(3013139) Helicobacter pylori Ag [Presence] in Stool
75
506
1.52
2.89
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
774
7310
1.33
2.87
4.3
4.0
mmol/l
2.8
2.8
0.17
730
6853
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
137
2.00
2.82
2.8
4.1
u/ml
0.2
0.4
1.85
11
69
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
47
2.79
2.82
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
53
2.67
2.80
1.9
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
79
544
1.49
2.78
1.1
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
31
3.25
2.78
1.6
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
65
429
1.55
2.78
5.6
4.3
ng/l
109.6
73.9
1.04
60
398
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
762
7203
1.31
2.64
3.9
3.7
mmol/l
1.4
1.5
2.42
719
6772
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
29
155
1.90
2.64
1.2
2.8
g/l
0.0
0.9
2.46
22
146
(1616796) Gas panel - Central venous blood
25
127
1.99
2.62
2.3
2.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
93
2.18
2.62
2.0
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
74
2.32
2.59
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
74
514
1.48
2.51
4.0
2.3
ml/min/173m2
77.8
74.1
0.28
26
201
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
180
1.81
2.50
2.0
1.4
u/ml
124.4
102.5
—
8
33
(40768446) Kidney Pathology biopsy report
9
26
3.48
2.48
2.3
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
72
499
1.48
2.48
1.3
1.3
—
37.1
—
0
25
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
109
2.04
2.47
1.2
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
62
417
1.52
2.46
3.4
4.2
kpa
5.1
5.1
0.07
57
390
(44813793)
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
57
2.48
2.45
1.4
1.5
u/ml
0.2
0.7
—
6
19
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
27
145
1.89
2.44
1.3
1.2
u/ml
3.5
5.8
—
8
46
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
138
1.91
2.43
1.1
1.1
—
—
—
0
0
(3013512) EKG study
203
1669
1.28
2.39
3.3
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
61
412
1.51
2.38
3.3
4.2
ph
7.4
7.4
—
6
53
(3023511) Choriogonadotropin [Units/volume] in Urine
53
347
1.56
2.38
1.2
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
17
4.14
2.36
1.4
1.5
umol/l
24.4
13.5
—
7
17
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
140
1.88
2.34
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
489
1.47
2.33
3.6
3.1
—
—
—
0
0
(3020891) Body temperature
33
192
1.74
2.32
2.8
4.7
—
—
—
0
0
(3000492) Spirometry study
104
781
1.37
2.32
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
282
2419
1.24
2.29
2.1
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
13
4.64
2.27
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
679
6368
1.24
2.27
5.7
4.6
mmol/mol
40.0
38.4
3.02
639
6000
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
120
1.94
2.27
2.4
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
164
1.79
2.25
1.2
2.5
g/l
8.9
10.3
1.29
22
150
(3010421) pH of Blood
27
150
1.82
2.22
4.0
2.6
ph
7.4
7.4
0.31
22
125
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
9
5.58
2.21
6.4
4.3
mmol/l
6.0
8.3
—
5
9
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
80
2.15
2.19
1.3
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
24
3.35
2.18
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
87
2.09
2.18
1.5
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
111
853
1.34
2.15
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
57
389
1.50
2.14
2.6
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
35
213
1.67
2.12
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
160
1.77
2.11
2.7
2.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
37
2.72
2.10
1.5
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
58
399
1.48
2.10
1.6
2.9
g/l
66.2
67.5
0.70
53
373
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
399
1.48
2.10
3.2
4.3
mmol/l
1.4
1.5
0.06
42
290
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
75
2.15
2.09
1.6
1.3
nmol/l
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
191
1.70
2.09
2.0
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
96
725
1.36
2.08
1.8
2.0
nmol/l
326.5
376.1
1.91
89
675
(44806420)
5
10
5.02
2.07
1.8
2.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
47
311
1.54
2.04
1.3
2.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
15
4.02
2.04
1.8
1.4
umol/l
15.3
18.1
—
6
15
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
26
3.09
2.01
1.6
1.3
u/l
19.3
13.7
—
8
21
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
25
425
0.58
2.01
1.4
1.6
—
—
—
0
0
(4094501)
26
149
1.77
1.96
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
120
1.85
1.94
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
27
2.98
1.94
1.3
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
45
2.46
1.93
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
45
2.46
1.93
1.1
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
33
2.74
1.93
1.6
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
71
2.13
1.93
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
71
2.13
1.93
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
71
2.13
1.93
1.5
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
61
433
1.44
1.91
2.6
2.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
74
544
1.39
1.90
2.3
2.3
—
17.7
—
0
37
(3028707) Methadone [Presence] in Urine by Screen method
43
284
1.54
1.90
2.6
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
268
1.55
1.90
8.3
12.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
72
2.10
1.87
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
59
2.22
1.84
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
147
1201
1.27
1.83
2.0
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
12
4.18
1.82
1.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
80
2.02
1.80
1.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
23
3.06
1.80
1.6
2.7
u/l
170.4
192.1
—
7
23
(3011412) CD3 cells [#/volume] in Blood
15
74
2.04
1.75
3.3
2.4
e9/l
1.4
1.3
—
7
39
(3012501) Base excess in Blood by calculation
22
125
1.78
1.73
3.6
2.6
mmol/l
1.7
2.5
1.04
12
76
(3027315) Oxygen [Partial pressure] in Blood
22
125
1.78
1.73
3.6
2.6
kpa
9.1
9.0
0.12
22
125
(3013290) Carbon dioxide [Partial pressure] in Blood
22
125
1.78
1.73
3.6
2.6
kpa
4.8
5.0
0.54
22
125
(3045788) Cell count panel - Pleural fluid
8
30
2.68
1.72
2.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
24
2.93
1.72
1.0
1.1
%
101.9
93.0
—
7
24
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
13
3.86
1.71
9.4
5.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
173
1.64
1.65
1.8
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
25
2.81
1.65
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
76
1.99
1.65
2.5
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
37
246
1.52
1.62
1.3
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
14
3.58
1.61
1.4
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
14
3.58
1.61
1.0
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
206
1.57
1.61
1.5
1.2
u/ml
184.5
236.6
0.76
21
122
(3021440) Promyelocytes/100 leukocytes in Blood
72
544
1.35
1.60
5.0
4.1
%
0.0
0.2
4.40
15
136
(40768443) Skin Pathology biopsy report
38
255
1.51
1.60
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
75
571
1.34
1.59
4.9
4.1
%
0.4
0.8
0.91
16
148
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
20
3.01
1.58
1.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
50
2.21
1.57
2.2
2.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
16
85
1.90
1.55
1.8
1.7
mmol/l
2.1
1.6
1.30
16
85
(3022145) Colonoscopy Study observation
94
742
1.30
1.55
1.5
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
69
521
1.35
1.55
5.2
4.2
%
0.0
0.1
0.82
14
112
(4198724)
13
64
2.05
1.54
3.0
1.8
—
—
—
0
0
(4306422)
22
130
1.71
1.54
1.1
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
8
33
2.44
1.54
44.5
29.8
ug/l
7.3
6.9
—
8
27
(3020393) Adenovirus Ag [Presence] in Stool
5
15
3.35
1.52
1.2
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
724
6931
1.19
1.51
3.6
3.4
mmol/l
1.3
1.2
0.35
684
6512
(3042733) HLA Ab [Presence] in Serum
6
21
2.87
1.50
7.5
3.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
58
2.08
1.49
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
64
482
1.35
1.47
2.7
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
205
1777
1.20
1.46
1.8
1.7
mmol/l
1.5
1.4
0.59
182
1541
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
28
2.51
1.45
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
28
2.51
1.45
1.3
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
30
196
1.55
1.44
2.9
4.8
kpa
8.8
8.9
0.04
25
184
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
45
321
1.42
1.42
1.7
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
135
1127
1.23
1.41
1.9
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
495
1.34
1.40
3.7
4.1
ug/l
3.3
15.5
0.76
53
394
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
96
1.79
1.39
1.3
1.1
g/l
1.3
1.4
0.59
17
89
(3015235) Bicarbonate [Moles/volume] in Capillary blood
24
151
1.60
1.36
2.8
2.5
mmol/l
24.1
24.6
0.13
19
136
(3022313) Gas panel - Capillary blood
43
308
1.42
1.34
3.5
4.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
47
2.14
1.34
1.5
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
47
2.14
1.34
4.7
2.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
144
1.61
1.33
1.3
1.3
u/ml
2.7
6.4
—
7
57
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
144
1.61
1.33
2.0
2.3
ug/min
38.3
107.0
1.14
15
90
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
152
1.59
1.33
1.8
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
509
1.32
1.32
2.5
3.3
pmol/l
4.7
4.6
0.05
58
457
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
44
318
1.40
1.31
1.5
2.3
u/l
40.1
38.6
0.17
38
289
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
114
1.68
1.29
2.1
2.2
%
16.7
16.6
—
8
63
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
18
2.79
1.28
2.4
5.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
30
202
1.50
1.28
1.1
1.2
u/ml
1.4
2.2
—
6
22
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
1.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
204
1.49
1.23
1.1
1.2
u/ml
6.0
17.3
—
7
34
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
45
2.01
1.23
5.3
3.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
85
1.78
1.23
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
85
1.78
1.23
1.1
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
94
768
1.25
1.21
1.7
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
419
1.33
1.21
2.3
2.7
e9/l
67.4
71.8
0.34
36
313
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
71
1.84
1.20
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
71
1.84
1.20
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
71
1.84
1.20
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
38
2.11
1.18
1.6
3.0
ug/l
21.3
233.6
—
8
33
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
27
392
0.68
1.18
1.8
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
30
207
1.46
1.16
1.4
1.6
—
182.5
—
0
8
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
19
118
1.62
1.15
1.4
1.7
—
1744.0
—
0
5
(3024932) HLA-DR beta [Type]
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
(4034850)
33
233
1.43
1.14
5.0
8.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
281
2547
1.15
1.14
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
103
1.66
1.13
2.4
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
67
531
1.28
1.12
5.0
3.8
%
0.4
0.5
0.06
14
104
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
7
30
2.34
1.12
1.4
3.1
umol/l
20.6
36.8
—
7
21
(3034426) Prothrombin time (PT)
7
30
2.34
1.12
1.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
81
1.74
1.09
2.5
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
67
534
1.27
1.08
1.3
1.4
iu/l
22.9
22.4
0.05
59
445
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
203
1.44
1.06
1.1
1.1
u/ml
2.6
2.8
—
8
54
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
237
1.41
1.06
1.2
1.1
u/ml
0.4
1.2
1.99
14
97
(40768793) Breast Pathology biopsy report
10
179
0.55
1.06
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
242
2185
1.14
1.04
3.5
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
557
1.26
1.02
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
139
1.52
1.00
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
23
332
0.69
1.00
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
158
1389
1.17
0.98
4.2
4.2
ug/l
2.1
2.3
0.10
148
1260
(3000475) Leukocytes [#/volume] in Synovial fluid
20
132
1.53
0.97
2.1
1.7
e6/l
11636.6
13424.9
0.11
12
107
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
92
1.64
0.97
1.3
1.5
mmol/l
10.3
11.9
—
5
16
(4268621)
16
100
1.61
0.97
2.3
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
108
1.58
0.97
1.8
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
54
1.86
0.97
3.5
2.5
—
—
—
0
0
(4024509)
9
50
1.81
0.96
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
259
1.36
0.96
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
76
626
1.23
0.95
2.4
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
166
1.46
0.95
2.1
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
51
1.77
0.94
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
35
260
1.36
0.94
1.1
1.1
u/ml
6.8
5.5
—
6
49
(3001019) Free T4 and TSH panel - Serum or Plasma
45
575
0.77
0.93
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
75
619
1.23
0.93
2.5
2.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
51
402
1.28
0.92
1.2
1.3
miu/ml
205.3
235.5
0.24
24
203
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
28
2.15
0.91
1.2
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
86
1.64
0.91
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
75
623
1.22
0.88
2.5
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
30
2.01
0.87
1.5
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
256
1.34
0.86
1.6
1.6
iu/ml
2.2
0.0
—
6
45
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
72
1.68
0.85
2.2
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
74
617
1.22
0.84
2.5
1.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
31
1.94
0.84
2.5
3.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
74
618
1.21
0.83
2.6
2.7
%
1.7
1.7
0.32
69
557
(3008898) HLA-B27 [Presence]
49
391
1.27
0.82
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
32
1.88
0.82
3.8
1.3
nmol/l
122.5
133.8
—
6
32
(3040151) Glucose [Moles/volume] in Capillary blood
12
73
1.65
0.82
1.2
5.7
mmol/l
4.9
6.8
—
7
62
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
47
1.71
0.80
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
465
1.24
0.80
4.2
3.1
mmol/l
1.2
1.2
0.32
50
394
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
286
1.31
0.79
2.2
2.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
156
1.42
0.79
1.1
1.1
u/ml
4.9
7.4
0.30
12
64
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
82
1.59
0.78
1.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
82
1.59
0.78
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
184
1664
1.13
0.78
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
449
1.24
0.78
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
213
1947
1.12
0.76
1.9
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
396
1.25
0.76
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
67
1.65
0.75
2.8
3.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
83
1.57
0.75
1.1
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
24
2.09
0.74
2.8
2.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
24
2.09
0.74
2.6
2.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
29
219
1.33
0.74
1.1
1.1
u/ml
6.9
5.1
0.17
15
118
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
55
1.64
0.73
1.2
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
25
2.01
0.72
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
39
1.80
0.72
2.0
3.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
29
220
1.33
0.72
1.5
1.4
pmol/l
146.0
108.1
0.14
29
214
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
230
1.31
0.70
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
49
595
0.81
0.70
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
41
1.71
0.70
1.3
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.1
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
152
1.39
0.69
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
320
1.26
0.69
1.9
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
61
1.65
0.68
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
110
1.46
0.68
1.5
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
119
1.44
0.67
1.3
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
28
1.79
0.66
2.0
3.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
62
1.62
0.65
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
207
1.31
0.64
1.1
1.1
u/ml
0.2
1.6
1.15
11
93
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
172
1.35
0.64
1.1
1.1
u/ml
4.2
5.3
—
9
65
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
172
1.35
0.64
2.1
1.5
e6/l
19.9
12.3
0.21
16
134
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
23
172
1.35
0.64
2.1
1.6
e6/l
449.4
790.7
0.19
17
139
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
78
898
0.86
0.64
1.4
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
234
1.29
0.63
1.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
15
104
1.45
0.62
1.1
1.3
—
54.0
—
0
7
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
705
1.16
0.61
1.2
1.2
iu/ml
135.2
140.2
0.05
37
291
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
96
1.47
0.61
2.5
2.9
u/ml
4.6
47.9
0.51
14
87
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
54
639
0.84
0.61
1.3
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
50
1.61
0.61
1.1
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
51
1.57
0.60
1.4
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
148
1.36
0.60
1.1
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
0.8
—
0
15
(3044927) Protein electrophoresis panel - Urine
8
53
1.51
0.58
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
141
1.35
0.56
1.6
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
230
1.27
0.56
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
195
1.29
0.54
1.2
1.5
nmol/l
0.4
0.4
0.05
20
162
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
80
905
0.87
0.53
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
66
573
1.16
0.53
2.6
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
74
1.49
0.53
1.6
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
259
1.24
0.53
1.7
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
20
152
1.32
0.52
2.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
63
1.43
0.52
1.1
1.1
nmol/l
371.0
432.6
—
9
55
(3042631) Mycobacterium sp identified in Specimen
9
63
1.43
0.52
2.2
2.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
50
425
1.19
0.52
1.6
2.3
u/ml
91.3
42.0
0.29
50
408
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
65
1.39
0.50
1.3
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
102
918
1.12
0.50
1.7
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
261
1.23
0.50
1.3
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
41
1.47
0.50
1.2
1.2
—
1.8
—
0
5
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
93
1.40
0.48
2.2
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
77
683
1.14
0.48
3.6
3.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
68
1.48
0.47
7.5
10.2
mmol/l
0.5
0.6
—
10
63
(3032773) Endomysium IgG Ab [Titer] in Serum
14
103
1.36
0.45
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
91
821
1.12
0.44
2.9
2.7
ug/l
0.7
0.7
0.24
61
476
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
148
1.29
0.43
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
148
1.29
0.43
1.4
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
201
1889
1.08
0.43
3.7
4.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
5
31
1.62
0.43
1.4
4.5
—
7.4
—
0
10
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
56
1.43
0.42
1.3
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
176
1.26
0.42
2.4
2.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
58
1.38
0.41
3.3
2.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
88
1.37
0.40
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
98
1071
0.91
0.40
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
66
1.37
0.38
1.4
2.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.2
1.1
—
16.5
—
0
8
(3035285) Chloride [Moles/volume] in Venous blood
9
68
1.33
0.37
1.4
2.5
mmol/l
105.8
105.3
—
9
68
(3041354) Potassium [Moles/volume] in Venous blood
9
68
1.33
0.37
1.4
2.5
mmol/l
4.1
4.0
—
9
68
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
107
1.31
0.37
1.6
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
69
1.31
0.37
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
202
0.79
0.37
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
108
997
1.09
0.36
2.0
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
43
1.40
0.35
2.2
3.5
u/ml
1676.3
628.2
—
6
43
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
120
1117
1.09
0.34
3.7
3.7
%
24.5
21.4
1.08
46
467
(1761482) Bacteria [#/volume] in Urine by Culture
17
136
1.25
0.33
3.6
4.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
86
0.70
0.33
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
88
0.68
0.33
1.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
54
1.30
0.30
3.1
1.9
ug/l
11.4
23.8
—
7
54
(3037756) Immunofixation for Serum or Plasma
11
84
1.31
0.30
1.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.0
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
149
1.21
0.28
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
194
0.82
0.28
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
194
0.82
0.28
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
117
0.77
0.27
1.7
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
64
1.25
0.27
4.8
2.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
119
0.75
0.27
1.2
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.1
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
86
1.28
0.26
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
73
1.24
0.25
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
234
0.85
0.25
1.8
1.8
iu/l
3.7
5.7
—
7
84
(3019225) pH of Specimen
61
561
1.09
0.24
2.7
3.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
76
1.19
0.24
2.2
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
161
1.18
0.24
1.7
1.6
—
—
—
0
0
(4010399)
50
457
1.10
0.23
1.6
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
38
1.32
0.23
1.2
1.6
u/field
4.4
6.0
—
5
27
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
190
1.16
0.23
2.4
2.5
umol/l
4.7
6.4
0.59
16
145
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
39
1.28
0.23
1.2
1.1
miu/ml
1261.0
1590.9
—
5
39
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
92
0.76
0.22
2.3
2.3
nmol/l
26.0
23.3
—
7
87
(44790049)
7
94
0.74
0.22
2.9
1.6
—
—
—
0
0
(44806118)
7
94
0.74
0.22
2.9
1.6
—
—
—
0
0
(44790047)
7
94
0.74
0.22
2.9
1.6
—
—
—
0
0
(44790048)
7
94
0.74
0.22
2.9
1.6
—
—
—
0
0
(1002224) Polysomnography panel
40
362
1.11
0.22
1.0
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
4.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
101
0.79
0.21
1.3
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
13
0.00
0.21
0.0
3.9
—
49.5
—
0
13
(3044007) Cell count panel - Peritoneal fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.9
—
376.0
—
0
7
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
49
1.23
0.20
1.0
1.2
—
83.5
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
49
1.23
0.20
1.0
1.2
—
46.2
—
0
5
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
100
1.20
0.18
2.3
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
60
1.17
0.18
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
214
1.12
0.17
1.4
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
69
0.72
0.17
1.0
1.6
—
—
—
0
0
(4027681)
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
370
0.92
0.16
1.4
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
52
487
1.07
0.15
1.6
1.6
mu/l
288.8
309.7
0.29
47
436
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
79
1.14
0.15
1.1
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
80
1.13
0.15
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
89
0.78
0.14
1.0
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
189
1.11
0.14
2.6
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
103
1.17
0.13
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
100
0.80
0.13
1.4
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
34
315
1.08
0.13
1.6
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
765
1.05
0.13
3.5
3.6
%
31.2
31.8
0.19
56
545
(3019832) Treponema pallidum Ab [Presence] in Serum
153
1567
0.97
0.10
1.8
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
154
1.11
0.10
1.1
1.1
—
—
—
0
0
(4035726)
55
526
1.05
0.10
1.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
37
391
0.94
0.09
1.6
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
61
0.82
0.08
1.6
2.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.0
1.6
g/l
0.8
1.0
—
5
62
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
153
0.91
0.07
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
83
0.84
0.07
1.3
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
84
0.83
0.07
2.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
45
468
0.96
0.07
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
45
468
0.96
0.07
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
89
1.12
0.07
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
101
0.89
0.06
1.1
4.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
45
467
0.96
0.06
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
70
719
0.97
0.06
5.7
5.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
295
2978
0.99
0.06
2.4
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
53
514
1.03
0.05
1.5
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
27
257
1.05
0.05
1.5
1.6
nmol/l
41.6
39.8
0.14
27
250
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
128
1300
0.98
0.05
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
110
1.09
0.05
6.0
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
109
0.92
0.04
1.2
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
37
380
0.97
0.03
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
46
470
0.98
0.02
1.5
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
142
1.06
0.02
1.5
3.2
e9/l
4.7
4.1
0.37
15
142
(3005033) Fetal Nuchal fold Thickness US
37
379
0.98
0.02
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
163
1.04
0.01
1.9
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
94
1.06
0.01
1.1
1.2
u/l
19.7
22.5
—
10
81
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
98
1.02
0.00
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
142
0.99
0.00
2.6
3.2
mg/l
13.5
29.6
—
8
91
(3037121) Protein [Mass/volume] in Urine
24
238
1.01
0.00
2.9
3.6
g/l
0.7
0.3
0.91
18
104
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
41
412
0.99
0.00
1.6
1.8
mg/l
2.5
3.2
0.53
31
288
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
125
1.04
0.00
1.4
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
105
1.05
0.00
2.3
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
145
1.04
0.00
1.6
3.4
%
58.6
55.1
0.63
15
145
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
155
1.03
0.00
1.1
1.1
u/ml
2.3
2.4
—
6
81
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.6
—
2.3
—
0
5
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
8.4
—
0
5
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.0
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
59
0.85
0.00
1.4
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
58
0.86
0.00
1.2
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
78
0.90
0.00
1.7
1.4
nmol/l
47.2
32.9
—
7
66
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
1.4
—
356.2
—
0
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
12.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
8
0.00
0.00
0.0
3.3
—
210.9
—
0
8
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.8
—
0
7
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.2
—
0.9
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
59
0.85
0.00
3.4
1.5
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ST19_CONTU_TOES_WO_DAMAGE_NAIL – Contusion of toe(s) without damage to nail

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).